New paper out in Nature Communications: Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2
We are excited to share our latest publication on the development of the first SOCS2 inhibitors | Just out in Nature Communications Our lab has worked relentlessly over many many years to develop phosphotyrosine-based covalent ligands of the E3 ligase SOCS2…